Ross C. Gruber

1.2k total citations
24 papers, 926 citations indexed

About

Ross C. Gruber is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ross C. Gruber has authored 24 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Ross C. Gruber's work include Protein Tyrosine Phosphatases (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Immune Cell Function and Interaction (5 papers). Ross C. Gruber is often cited by papers focused on Protein Tyrosine Phosphatases (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Immune Cell Function and Interaction (5 papers). Ross C. Gruber collaborates with scholars based in United States, France and Netherlands. Ross C. Gruber's co-authors include Paul T. Massa, George P. Christophi, Chad A. Hudson, Bridget Shafit‐Zagardo, Burk Jubelt, Joel R. Wilmore, David A. Lawrence, Alex Ray, Fernando Macián and Dimitry Ofengeim and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Ross C. Gruber

24 papers receiving 921 citations

Peers

Countries citing papers authored by Ross C. Gruber

Since Specialization

Citations

This map shows the geographic impact of Ross C. Gruber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross C. Gruber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross C. Gruber more than expected).

Fields of papers citing papers by Ross C. Gruber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross C. Gruber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross C. Gruber. The network helps show where Ross C. Gruber may publish in the future.

Co-authorship network of co-authors of Ross C. Gruber

This figure shows the co-authorship network connecting the top 25 collaborators of Ross C. Gruber. A scholar is included among the top collaborators of Ross C. Gruber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross C. Gruber. Ross C. Gruber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis 2024 ·Nature Communications ·Ross C. Gruber, (unknown), (unknown), (unknown), Michael R. Dufault, Nellwyn Hagan, Nathalie Chrétien, (unknown), Timothy R. Hammond, (unknown), Sean K. Ryan, Andrew Macklin, Mindy Zhang, Nilesh Pande, Evis Havari, Timothy J. Turner, Anthony Chomyk, (unknown), Bruce D. Trapp, Dimitry Ofengeim	11
2	Comparative CNS Pharmacology of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis 2024 ·Drugs in R&D ·Timothy J. Turner, (unknown), Ross C. Gruber, Dimitry Ofengeim	17
3	Evaluating the Effect of BTK Inhibitor Tolebrutinib in Human Tri-culture (P1-1.Virtual) 2022 ·Neurology ·Ross C. Gruber, (unknown), (unknown), Sean K. Ryan, (unknown), (unknown), Timothy J. Turner, Dimitry Ofengeim	5
4	RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis 2021 ·Cell Reports ·Matija Zelic, Fabrizio Pontarelli, Lisa Woodworth, Cheng Zhu, Amy Mahan, Yi Ren, (unknown), Ross C. Gruber, (unknown), (unknown), Lilu Guo, (unknown), (unknown), Pontus Ørning, Egil Lien, Alexei Degterev, Timothy R. Hammond, Dimitry Ofengeim	90
5	Establishing a Role for the Bruton’s Tyrosine Kinase Inhibitor Tolebrutinib in Modulating Neuroinflammation and Disease Progression in MS (1974) 2021 ·Neurology ·Ross C. Gruber, Michael R. Dufault, Nathalie Chrétien, Jonathan D. Proto, Mindy Zhang, Evis Havari, Timothy J. Turner, Anthony Chomyk, (unknown), Bruce D. Trapp, Dimitry Ofengeim	1
6	Central Effects of BTK Inhibition in Neuroinflammation (808) 2020 ·Neurology ·Ross C. Gruber, Nathalie Chrétien, Michael R. Dufault, Jonathan D. Proto, Mindy Zhang, (unknown), Evis Havari, Tarek A. Samad, Timothy J. Turner, Anthony Chomyk, (unknown), Bruce D. Trapp, Dimitry Ofengeim	10
7	Akt3-Mediated Protection Against Inflammatory Demyelinating Disease 2019 ·Frontiers in Immunology ·(unknown), Alex Ray, Ross C. Gruber, Yongwei Zhang, (unknown), Fernando Macián, Bridget Shafit‐Zagardo	34
8	Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy 2018 ·Cell Reports ·Enric Mocholí, (unknown), Yaïr Botbol, Ross C. Gruber, Alex Ray, Sebastiaan J. Vastert, Bridget Shafit‐Zagardo, Paul J. Coffer, Fernando Macián	45
9	The role of TAM family receptors and ligands in the nervous system: From development to pathobiology 2018 ·Pharmacology & Therapeutics ·Bridget Shafit‐Zagardo, Ross C. Gruber, (unknown)	65
10	Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure 2017 ·Glia ·Alex Ray, (unknown), Ross C. Gruber, (unknown), Maria Gulinello, (unknown), Cedric S. Raine, (unknown), (unknown), Bridget Shafit‐Zagardo	56
11	Macroautophagy regulates T helper cell activation and tolerance 2016 ·The Journal of Immunology ·(unknown), Enric Mocholí, Ross C. Gruber, Bridget Shafit‐Zagardo, Fernando Macián	1
12	Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis 2014 ·Journal of Neuroscience ·Ross C. Gruber, Alex Ray, (unknown), (unknown), (unknown), Pablo Garcı́a de Frutos, Bridget Shafit‐Zagardo	56
13	Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients 2011 ·Journal of the Neurological Sciences ·George P. Christophi, (unknown), Ross C. Gruber, Cornelia Mihai, Luis J. Mejico, Paul T. Massa, Burk Jubelt	13
14	Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients 2011 ·Clinical Immunology ·George P. Christophi, Ross C. Gruber, (unknown), (unknown), Burk Jubelt, Paul T. Massa	88
15	Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype 2009 ·Laboratory Investigation ·George P. Christophi, (unknown), Chad A. Hudson, (unknown), Ross C. Gruber, (unknown), Scott D. Blystone, Burk Jubelt, Paul T. Massa	71
16	Promoter‐specific induction of the phosphatase SHP‐1 by viral infection and cytokines in CNS glia 2008 ·Journal of Neurochemistry ·George P. Christophi, Chad A. Hudson, Ross C. Gruber, (unknown), Paul T. Massa	17
17	Induction of IL-33 expression and activity in central nervous system glia 2008 ·Journal of Leukocyte Biology ·Chad A. Hudson, George P. Christophi, Ross C. Gruber, Joel R. Wilmore, David A. Lawrence, Paul T. Massa	173
18	SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients 2008 ·Laboratory Investigation ·George P. Christophi, Chad A. Hudson, Ross C. Gruber, (unknown), Cornelia Mihai, Luis J. Mejico, Burk Jubelt, Paul T. Massa	56
19	Modulation of Macrophage Infiltration and Inflammatory Activity by the Phosphatase SHP-1 in Virus-Induced Demyelinating Disease 2008 ·Journal of Virology ·George P. Christophi, Chad A. Hudson, (unknown), Ross C. Gruber, Paul T. Massa	43
20	Regulation of avoidant behaviors and pain by the anti-inflammatory tyrosine phosphatase SHP-1 2006 ·PubMed ·Chad A. Hudson, George P. Christophi, Ling Cao, Ross C. Gruber, Paul T. Massa	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact